BridgeBio Pharma, Inc. (BBIO) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 15.09B |
| Enterprise Value | 17.25B |
| P/E Ratio | -18.13 |
| PEG Ratio | 1.98 |
| Price/Sales Ratio | 22.81 |
| Price/Book Ratio | -5.8 |
| Enterprise/Revenue | 27.13 |
| Enterprise/EBITDA | -26.18 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | -1.25 |
| Operating Margin | -0.98 |
| Return On Assets | -0.53 |
| Return On Equity | 0.36 |
| Revenue | 502.08M |
| Revenue/Share | 2.98 |
| Gross Profit | 473.81M |
| EBITDA | -672.88M |
| Net Income | -729.31M |
| Diluted EPS | -3.79 |
| Total Cash | 940.19M |
| Total Cash/Share | 4.83 |
| Total Debt | 3.38B |
| Total Debt/Equity | -1.49 |
| Current Ratio | 1.44 |
| Book Value Per Share | -11.65 |
| 52-Week Change | 70.37 |
| 52-Week High | 84.94 |
| 52-Week Low | 38.58 |
| Moving Average 50 Days | 70.28 |
| Moving Average 200 Days | 67.14 |
| Average Volume | 2.47M |
| Shares Outstanding | 195.86M |
| % Held by Institutions | 98.68 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |